EUVIMEDEUVIMED entdecken
Crossref

Safety and Efficacy Study of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients

Shikha Shukla, Nimisha Kakadia

International Journal of Drug Delivery Technology · 31.03.2026 · 16 (3s)

DOI: 10.25258/ijddt.16.3s.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 31.03.2026. Verfasst von Shikha Shukla und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Modifying Antirheumatic Drugs (DMARDs) are integral to managing Rheumatoid Arthritis (RA), yet their long-term safety, efficacy, and cost-effectiveness remain under-explored in the Indian population.

Objective

To evaluate the safety, efficacy, prescription patterns, medication adherence, quality of life, and costeffectiveness of biological and non-biological DMARDs in RA patients.

Methods

This is a prospective, retrospective, open-labeled observational study conducted at two clinical sites in Gujarat, India. A total of 450 RA patients aged 18–75 years were enrolled in the study. Clinical data, lab parameters, and qualityof- life assessments were recorded.

Results

Female patients predominated. Most participants were aged 40–50 years with RA duration exceeding 10 years. Hydroxychloroquine and naproxen were the most prescribed drugs. Lab results revealed elevated ESR and CRP.

Conclusion

The study provides valuable insight into DMARD usage, safety, efficacy, and prescription trends among Indian RA patients, supporting a shift towards biological DMARDs with monitored cost-effectiveness and improved patient outcomes.

Zitieren

APA

Shukla, S., & Kakadia, N. (2026). Safety and Efficacy Study of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients. International Journal of Drug Delivery Technology, 16(3s). https://doi.org/10.25258/ijddt.16.3s.11

Vancouver

Shukla S, Kakadia N. Safety and Efficacy Study of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients. International Journal of Drug Delivery Technology. 2026;16(3s). doi:10.25258/ijddt.16.3s.11

BibTeX
@article{Shukla2026,
  author = {Shukla, Shikha and Kakadia, Nimisha},
  title = {Safety and Efficacy Study of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {3s},
  doi = {10.25258/ijddt.16.3s.11}
}
Kostenlos starten →